Background: Accumulating epidemiological evidence from several populations supports the important role of the Mediterranean-type diet (MeDi) in reducing the risk for age-related diseases such as Alzheimer's disease (AD). However, the relevant literature is clearly deficient for most Mediterranean countries that more closely adhere to the originally described MeDi. Greece resides in the Mediterranean basin, and older generations traditionally adhere to a MeDi. Methods: We here present the design and the preliminary baseline characteristics of the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD). The HELIAD is a population-based, multidisciplinary, collaborative study designed to estimate the prevalence and incidence of AD, other dementias, mild cognitive impairment, and other neuropsychiatric conditions of aging in the Greek population and to investigate associations between nutrition and cognitive dysfunction/age-related neuropsychiatric diseases in this Mediterranean population. The study also ascertains several demographic, medical, social, environmental, clinical, nutritional, and neuropsychological determinants and lifestyle activities. Results: In total, 1,050 participants of a random sample have already completed the initial evaluation. The subjects were, on average, 73.4 (SD = 6.0) years old, 60% of the sample were female, and most of the participants were poorly educated with an average of 5.41 (SD = 3.5) years of education. The performance on the neuropsychological tests was equivalent to the average scores of previous normative Greek samples. More than one third of the population under investigation was considered to be at high risk for malnutrition. Conclusions: The HELIAD may provide important data for expanding our knowledge regarding the prevalence, incidence, and risk factors of AD and several other neuropsychiatric diseases in the Mediterranean region.

Keywords:
Mediterranean-type diet, Alzheimer’s disease, HELIAD
1.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117.
2.
Tsolaki M, Fountoulakis C, Pavlopoulos Ι, Chatzi Ε, Kazis Α: Prevalence and incidence of Alzheimer's disease and other dementing disorders in Pylea, Greece. Am J Alzheimers Dis Other Demen 1999;14:138-148.
3.
Luchsinger JA, Noble JM, Scarmeas N: Diet and Alzheimer's disease. Curr Neurol Neurosci Rep 2007;7:366-372.
4.
Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA: Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006;59:912-921.
5.
Scarmeas N, Louis ED: Mediterranean diet and essential tremor: a case-control study. Neuroepidemiology 2007;29:170-177.
6.
Keys A: Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, Harvard UP, 1980.
7.
Supreme Scientific Health Council, Ministry of Health and Welfare of Greece: Dietary guidelines for adults in Greece. Arch Hellen Med 1999;16:516-524.
8.
Scarmeas N, Stern Y, Mayeux R, Luchsinger JA: Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 2006;63:1709-1717.
9.
Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, Stern Y: Physical activity, diet, and risk of Alzheimer disease. JAMA 2009;302:627-637.
10.
Gu Y, Luchsinger JA, Stern Y, Scarmeas N: Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis 2010;22:483-492.
11.
Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Chirico M, Capurso A, Panza F: Whole-diet approach, Mediterranean diet, and Alzheimer disease. Arch Neurol 2007;64:606, author reply 607.
12.
Keeter S, Miller C, Kohut A, Groves RM, Presser S: Consequences of reducing nonresponse in a national telephone survey. Public Opin Q 2000;64:125-148.
13.
Heegaard KM, Holm-Pedersen P, Bardow A, Hvidtfeldt UA, Gronbaek M, Avlund K: The Copenhagen Oral Health Senior Cohort: design, population and dental health. Gerodontology 2011;28:165-176.
14.
Morton LM, Cahill J, Hartge P: Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 2006;163:197-203.
15.
Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, Brayne C; Medical Research Council Cognitive Function and Ageing Collaboration: A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013;382:1405-1412.
16.
Galea S, Tracy M: Participation rates in epidemiologic studies. Ann Epidemiol 2007;17:643-653.
17.
Panagiotakos DB, Pitsavos C, Stefanadis C: Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 2006;16:559-568.
18.
Scarmeas N, Stern Y: Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep 2004;4:374-380.
19.
Scarmeas N, Levy G, Tang MX, Manly J, Stern Y: Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 2001;57:2236-2242.
20.
Schiele F, de Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, Martins MC, Sans S, Sass C, Visvikis S, de Backer G, Siest G: Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 2000;152:475-488.
21.
Hadjigeorgiou GM, Stefanidis I, Dardiotis E, Aggellakis K, Sakkas GK, Xiromerisiou G, Konitsiotis S, Paterakis K, Poultsidi A, Tsimourtou V, Ralli S, Gourgoulianis K, Zintzaras E: Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol 2007;14:1275-1280.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.